Target：GSK3β

Fields：EGFR tyrosine kinase inhibitor resistance;ErbB signaling pathway;Chemokine signaling pathway;Cell cycle;mTOR signaling pathway;PI3K-Akt signaling pathway;Wnt signaling pathway;Hedgehog signaling pathway;Axon guidance;Hippo signaling pathway;Focal adhesion;Signaling pathways regulating pluripotency of stem cells;IL-17 signaling pathway;T cell receptor signaling pathway;B cell receptor signaling pathway;Neurotrophin signaling pathway;Dopaminergic synapse;Insulin signaling pathway;Melanogenesis;Prolactin signaling pathway;Thyroid hormone signaling pathway;Insulin resistance;Non-alcoholic fatty liver disease;Cushing syndrome;Growth hormone synthesis, secretion and action;Alcoholic liver disease;Alzheimer disease;Prion disease;Pathways of neurodegeneration - multiple diseases;Shigellosis;Yersinia infection;Hepatitis C;Measles;Human cytomegalovirus infection;Human papillomavirus infection;Kaposi sarcoma-associated herpes

Gene Name：GSK3B

Protein Name：Glycogen synthase kinase-3 beta

Human Gene Id：2932

Human Swiss Prot No：P49841

Mouse Gene Id：56637

Mouse Swiss Prot No：Q9WV60

Rat Gene Id：84027

Rat Swiss Prot No：P18266

Immunogen：Synthesized phospho-peptide around the phosphorylation site of human GSK3β (phospho Ser9)

Specificity：Phospho-GSK3β (S9) Polyclonal Antibody detects endogenous levels of GSK3β protein only when phosphorylated at S9.

Formulation：Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Source：Polyclonal, Rabbit,IgG

Dilution：WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:10000.. IF 1:50-200

Purification：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration：1 mg/ml

Storage Stability：-15°C to -25°C/1 year(Do not lower than -25°C)

Other Name：GSK3B;Glycogen synthase kinase-3 beta;GSK-3 beta;Serine/threonine-protein kinase GSK3B

Observed Band(KD)：47kD

Background： The protein encoded by this gene is a serine-threonine kinase, belonging to the glycogen synthase kinase subfamily. It is involved in energy metabolism, neuronal cell development, and body pattern formation. Polymorphisms in this gene have been implicated in modifying risk of Parkinson disease, and studies in mice show that overexpression of this gene may be relevant to the pathogenesis of Alzheimer disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009],

Function：catalytic activity:ATP + [tau protein] = ADP + [tau protein] phosphate.,enzyme regulation:Inhibited when phosphorylated by AKT1.,function:Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates MUC1 in breast cancer cells, and decreases the interaction of MUC1 with CTNNB1/beta-catenin.,PTM:Phosphorylated by AKT1 and ILK1.,similarity:Belongs to the protein kinase superfamily.,similarity:Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. GSK-3 subfamily.,similarity:Contains 1 protein kinase domain.,subunit:Monomer (By similarity). Interacts with CABYR, MUC1, NIN and PRUNE.,tissue specificity:Expressed in testis, thymus, prostate

Subcellular Location：Cytoplasm . Nucleus . Cell membrane . The phosphorylated form shows localization to cytoplasm and cell membrane (PubMed:20937854). The MEMO1-RHOA-DIAPH1 signaling pathway controls localization of the phosphorylated form to the cell membrane (PubMed:20937854). .

Expression：Expressed in testis, thymus, prostate and ovary and weakly expressed in lung, brain and kidney. Colocalizes with EIF2AK2/PKR and TAU in the Alzheimer disease (AD) brain.